Key alterations in transcription factors, such as carbohydrate response element-binding protein (ChREBP) and sterol regulatory element-binding protein 1 (SREBP-1), also play vital roles in NAFLD pathogenesis [6,7]. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatotic liver disease.